Here we demonstrate that both Vps33b and Vipar deficient mice develop a skin disease that is similar to patients with ARC syndrome, with keratinocyte hyperplasia and hypertrophy, hypergranulosis, hyperkeratosis and ultrastructural defects in the SC. Here, VIPAS39 is linked to Hyperkeratosis.